93 related articles for article (PubMed ID: 23639410)
1. Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer.
Jakobsen JN; Santoni-Rugiu E; Ravn J; Sørensen JB
Eur J Cancer; 2013 Jul; 49(11):2494-503. PubMed ID: 23639410
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy followed by surgery on the basis of biomarker examination for patients with advanced non-small cell lung cancer.
Yokomise H; Liu D; Ishikawa S; Go T; Gotoh M; Okuda M; Tarumi S; Kasai Y; Matsuura N
Anticancer Res; 2013 Dec; 33(12):5597-602. PubMed ID: 24324104
[TBL] [Abstract][Full Text] [Related]
3. Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer.
Okuda K; Sasaki H; Dumontet C; Kawano O; Yukiue H; Yokoyama T; Yano M; Fujii Y
Lung Cancer; 2008 Oct; 62(1):105-12. PubMed ID: 18395930
[TBL] [Abstract][Full Text] [Related]
4. Customized Adjuvant Chemotherapy Based on Biomarker Examination May Improve Survival of Patients Completely Resected for Non-small-cell Lung Cancer.
Liu D; Nakashima N; Nakano J; Tarumi S; Matsuura N; Nakano T; Nii K; Tokunaga Y; Go T; Yokomise H
Anticancer Res; 2017 May; 37(5):2501-2507. PubMed ID: 28476819
[TBL] [Abstract][Full Text] [Related]
5. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two ERCC1 antibodies as prognostic and predictive biomarkers for early non-small cell lung cancer.
Muley TR; Sianidou M; Thomas M; Bischoff H; Dienemann H; Meister M; Schneider MA; Schnabel PA; Warth A
Anticancer Res; 2014 Jul; 34(7):3707-13. PubMed ID: 24982391
[TBL] [Abstract][Full Text] [Related]
7. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
[TBL] [Abstract][Full Text] [Related]
8. Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer.
Jakobsen JN; Sørensen JB
Cancer Chemother Pharmacol; 2012 Feb; 69(2):289-99. PubMed ID: 22130585
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
10. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
[TBL] [Abstract][Full Text] [Related]
11. ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy.
Hwang IG; Ahn MJ; Park BB; Ahn YC; Han J; Lee S; Kim J; Shim YM; Ahn JS; Park K
Cancer; 2008 Sep; 113(6):1379-86. PubMed ID: 18623378
[TBL] [Abstract][Full Text] [Related]
12. High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC).
Sonnweber B; Dlaska M; Skvortsov S; Dirnhofer S; Schmid T; Hilbe W
J Clin Pathol; 2006 Mar; 59(3):255-9. PubMed ID: 16505275
[TBL] [Abstract][Full Text] [Related]
13. Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapy.
Vassalou H; Stathopoulos E; Fiolitaki G; Koutsopoulos A; Voutsina A; Georgoulias V; Mavroudis D
Lung Cancer; 2013 Nov; 82(2):324-9. PubMed ID: 23993732
[TBL] [Abstract][Full Text] [Related]
14. [ERCC1 and lung cancer].
Planchard D; Olaussen KA; Soria JC
Rev Mal Respir; 2010 Apr; 27(4):387-94. PubMed ID: 20403548
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients.
Jakobsen JN; Santoni-Rugiu E; Sørensen JB
Cancer Chemother Pharmacol; 2014 Jan; 73(1):43-51. PubMed ID: 24220933
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical comparison of biomarker expression in biopsy and surgical specimens of non-small cell lung cancer.
Okimoto T; Tsubata Y; Sutani A; Fuchita H; Koba N; Hotta T; Hamaguchi M; Miura K; Hamaguchi S; Ohe M; Kuraki T; Harada Y; Maruyama R; Miyamoto N; Kishimoto K; Isobe T
Anticancer Res; 2014 Jun; 34(6):2755-61. PubMed ID: 24922636
[TBL] [Abstract][Full Text] [Related]
17. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
Vilmar A; Sørensen JB
Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
[TBL] [Abstract][Full Text] [Related]
18. EGFR, c-erbB-2 and ki-67 in NSCLC and preneoplastic bronchial lesions.
Meert AP; Martin B; Verdebout JM; Feoli F; Mascaux C; Ninane V; Sculier JP
Anticancer Res; 2006; 26(1A):135-8. PubMed ID: 16475689
[TBL] [Abstract][Full Text] [Related]
19. Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer.
Jakobsen JN; Santoni-Rugiu E; Sørensen JB
Histopathology; 2014 Feb; 64(3):412-20. PubMed ID: 24266856
[TBL] [Abstract][Full Text] [Related]
20. Predicting non-small cell lung cancer expression of epidermal growth factor receptor and matrix metalloproteinase 9 from immunohistochemical staining of diagnostic biopsy samples.
Ferrigan L; Wallace WA
Eur J Cancer; 2004 Jul; 40(10):1589-92. PubMed ID: 15196544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
